Erratum: MCAO-induced neuronal loss via NR2A mediated prosurvival pathways(Front. Pharmacol. (2019) 10 (297), 10.3389/fphar.2019.00297)

Fawad Ali Shah, Gongping Liu, Lina T. Al Kury, Alam Zeb, Phil Ok Koh, Muzaffar Abbas, Tao Li, Xifei Yang, Fang Liu, Yuhua Jiang, Shupeng Li

Research output: Contribution to journalComment/debate

1 Scopus citations

Abstract

A corrigendum on Melatonin Protects MCAO-Induced Neuronal Loss via NR2A Mediated Prosurvival Pathways by Shah FA, Liu G, Al Kury LT, Zeb A, Koh P-O, Abbas M, Li T, Yang X, Liu F, Jiang Y and Li S (2019). Front. Pharmacol. 10:297. doi: 10.3389/fphar.2019.00297 Phil-Ok Koh was not included as an author in the published article. The corrected Author Contributions Statement appears below. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Original languageEnglish
Article number702
JournalFrontiers in Pharmacology
Volume10
Issue numberJUN
DOIs
StatePublished - 2019
Externally publishedYes

Keywords

  • AMPA receptor
  • Ischemic stroke
  • Melatonin
  • NMDA receptor
  • PI3K/AKT/GSK3 pathway

Fingerprint

Dive into the research topics of 'Erratum: MCAO-induced neuronal loss via NR2A mediated prosurvival pathways(Front. Pharmacol. (2019) 10 (297), 10.3389/fphar.2019.00297)'. Together they form a unique fingerprint.

Cite this